News from NORD

NIH Workshop Focuses on Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Publish date: May 10, 2017

 

NIH recently hosted a workshop to bring researchers together to discuss severe drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and possible genetic factors that might predispose individuals to greater risk.

Recommended Reading

Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Hematology and Oncology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Hematology and Oncology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Hematology and Oncology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Hematology and Oncology
Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
MDedge Hematology and Oncology
New diagnostic tool identifies severe ADAMTS13 deficiency
MDedge Hematology and Oncology
DTC genetic health risk tests: Beware
MDedge Hematology and Oncology
Patient Advocacy Groups Oppose AHCA
MDedge Hematology and Oncology
NORD Issues RFPs for 2017 Research Grants for Study of Rare Diseases
MDedge Hematology and Oncology
NORD Rare Action Network Issues Spring 2017 State Policy Legislative Tracker
MDedge Hematology and Oncology